<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00990288</url>
  </required_header>
  <id_info>
    <org_study_id>26078</org_study_id>
    <nct_id>NCT00990288</nct_id>
  </id_info>
  <brief_title>The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery</brief_title>
  <official_title>The Role of a Topical Hemostatic Agent in Reducing Blood Loss in Unilateral Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the agent, Floseal, can decrease the amount of
      blood patients lose after total knee replacement (TKR) surgery. If this product can be found
      to have an effect on bleeding, it may potentially reduce the problems associated with
      bleeding after knee replacement surgery such as pain, stiffness, and the need to have a blood
      transfusion. The subject's overall participation will be over a period of 6 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective double blind randomized clinical trial of patients requiring unilateral
      total knee arthroplasty. The patients will be randomized intra-operatively to receiving
      Floseal or no treatment.

      Both the patient and the observers will be blinded to whether the subject received Floseal or
      no treatment. Only the operating surgeons will be aware of whether Floseal or no treatment
      was given.

      As was performed in the pilot study, randomization of Floseal or no treatment will be
      performed using the sealed envelope technique. Randomization will occur at the time of
      surgery. The statistician is responsible for maintaining the randomization schedule and
      issuing the sealed envelopes. The inner envelope will contain whether Floseal or no treatment
      is to be given on a card which will be counter-signed by the surgeon at the time of surgery.
      The inner envelope will then be sealed, followed by sealing of the outer envelope. Following
      the procedure, the surgeon will then take the sealed and signed envelope to surgeon who will
      store and file it in a locked cabinet in his office. The patients study number will be on the
      outside surface of the envelopes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Hemoglobin on Day 0 Compared to Preoperatively</measure>
    <time_frame>preoperatively and on the day of surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Hemoglobin on Day 0 Compared to Preoperatively</measure>
    <time_frame>preoperatively and day of surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Hemoglobin On Day 1 Compared to Preoperatively</measure>
    <time_frame>preoperatively and one day after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Hematocrit on Day 1 Compared to Preoperatively</measure>
    <time_frame>preoperatively and 1 day after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Hemoglobin on Day 2 Compared to Preoperatively</measure>
    <time_frame>preoperatively and two days after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Hematocrit on Day 2 Compared to Preoperatively</measure>
    <time_frame>preoperatively and two days after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Drain Output</measure>
    <time_frame>24 hours postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Autologous Amount of Transfusion</measure>
    <time_frame>three days postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Homologous Amount of Transfusion</measure>
    <time_frame>three days postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Range of Motion on Day 3</measure>
    <time_frame>3days postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Pain Scale on Day 3</measure>
    <time_frame>3 days postoperatively</time_frame>
    <description>A VAS is a measurement instrument that tries to measure a characteristic or attitude that cannot easily be measured.
The pain VAS scale measures pain intensity on a scale of 0 to 10, with 0=no pain. A higher score indicates greater pain intensity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion at Six Weeks</measure>
    <time_frame>6 weeks postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Pain Scale at 6 Weeks</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>A VAS is a measurement instrument that tries to measure a characteristic or attitude that cannot easily be measured.
The pain VAS scale measures pain intensity on a scale of 0 to 10, with 0=no pain. A higher score indicates greater pain intensity.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">196</enrollment>
  <condition>Blood Loss</condition>
  <arm_group>
    <arm_group_label>Hemostatic Matrix</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 vials of Floseal applied once at the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hemostatic Matrix</intervention_name>
    <description>FloSeal will be administered following the cementing of all knee components. Prior to release of the tourniquet and after the cement has cured, it will be applied to cut, exposed bone ends as well as the intra-articular soft tissues by the use of a delivery syringe, Direct manual pressure with a gauze sponge will be applied following its application for 2 minutes, ensuring that it adheres to the bleeding bone surface.</description>
    <arm_group_label>Hemostatic Matrix</arm_group_label>
    <other_name>&quot;FloSeal&quot;, a thrombin and collagen based agent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Single Knee replacement for arthritis of the knee

        Exclusion Criteria:

          -  No inflammatory arthritis (ie. Rheumatoid arthritis)

          -  No allergies to cow meat (bovine allergies

          -  No history of bleeding disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark P Figgie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2009</study_first_submitted>
  <study_first_submitted_qc>October 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2009</study_first_posted>
  <results_first_submitted>February 4, 2013</results_first_submitted>
  <results_first_submitted_qc>November 10, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">December 12, 2017</results_first_posted>
  <last_update_submitted>November 10, 2017</last_update_submitted>
  <last_update_submitted_qc>November 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>To decrease blood loss during knee surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Inclusion Criteria:
1)Diagnosis of knee arthritis in patients medically suitable to undergo unilateral TKA.
Pre-operative Exclusion Criteria:
Known allergies to products of bovine origin.
History of bleeding disorders.
Pre- or peri-operative complication.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Hemostatic Matrix</title>
          <description>2 vials of Floseal applied once at the end of surgery</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>No intervention.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="97"/>
                <participants group_id="P2" count="99"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="97"/>
                <participants group_id="P2" count="99"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Hemostatic Matrix</title>
          <description>2 vials of Floseal applied once at the end of surgery</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>No intervention.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="97"/>
            <count group_id="B2" value="99"/>
            <count group_id="B3" value="196"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="73"/>
                    <measurement group_id="B3" value="93"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72.78" spread="8.90"/>
                    <measurement group_id="B2" value="70.40" spread="10.47"/>
                    <measurement group_id="B3" value="71.58" spread="9.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="71"/>
                    <measurement group_id="B3" value="136"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="99"/>
                    <measurement group_id="B3" value="196"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Hemoglobin on Day 0 Compared to Preoperatively</title>
        <time_frame>preoperatively and on the day of surgery</time_frame>
        <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis for various reasons</population>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hemoglobin on Day 0 Compared to Preoperatively</title>
          <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis for various reasons</population>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="96"/>
                <count group_id="O2" value="98"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.277" spread=".880"/>
                    <measurement group_id="O2" value="-1.241" spread=".883"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Hemoglobin on Day 0 Compared to Preoperatively</title>
        <time_frame>preoperatively and day of surgery</time_frame>
        <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hemoglobin on Day 0 Compared to Preoperatively</title>
          <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis.</population>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="96"/>
                <count group_id="O2" value="98"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.484" spread="2.637"/>
                    <measurement group_id="O2" value="-4.305" spread="2.682"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Hemoglobin On Day 1 Compared to Preoperatively</title>
        <time_frame>preoperatively and one day after surgery</time_frame>
        <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis for various reasons</population>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hemoglobin On Day 1 Compared to Preoperatively</title>
          <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis for various reasons</population>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="92"/>
                <count group_id="O2" value="94"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.528" spread="1.132"/>
                    <measurement group_id="O2" value="-1.816" spread="1.168"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Range of Motion on Day 3</title>
        <time_frame>3days postoperatively</time_frame>
        <population>Patients whose range of motion at 3 day followup appointment was taken were included in analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Range of Motion on Day 3</title>
          <population>Patients whose range of motion at 3 day followup appointment was taken were included in analysis.</population>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="97"/>
                <count group_id="O2" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.88" spread="14.54"/>
                    <measurement group_id="O2" value="68.96" spread="16.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Pain Scale on Day 3</title>
        <description>A VAS is a measurement instrument that tries to measure a characteristic or attitude that cannot easily be measured.
The pain VAS scale measures pain intensity on a scale of 0 to 10, with 0=no pain. A higher score indicates greater pain intensity.</description>
        <time_frame>3 days postoperatively</time_frame>
        <population>All patients whose pain score was collected were included in analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Pain Scale on Day 3</title>
          <description>A VAS is a measurement instrument that tries to measure a characteristic or attitude that cannot easily be measured.
The pain VAS scale measures pain intensity on a scale of 0 to 10, with 0=no pain. A higher score indicates greater pain intensity.</description>
          <population>All patients whose pain score was collected were included in analysis.</population>
          <units>points on visual analog pain scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="96"/>
                <count group_id="O2" value="98"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.99" spread="2.311"/>
                    <measurement group_id="O2" value="2.78" spread="2.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Hematocrit on Day 1 Compared to Preoperatively</title>
        <time_frame>preoperatively and 1 day after surgery</time_frame>
        <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis for various reasons</population>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hematocrit on Day 1 Compared to Preoperatively</title>
          <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis for various reasons</population>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="92"/>
                <count group_id="O2" value="94"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.075" spread="3.298"/>
                    <measurement group_id="O2" value="-5.749" spread="3.652"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Range of Motion at Six Weeks</title>
        <time_frame>6 weeks postoperatively</time_frame>
        <population>Patients whose range of motion at 6-week followup appointment was taken were included in analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Range of Motion at Six Weeks</title>
          <population>Patients whose range of motion at 6-week followup appointment was taken were included in analysis.</population>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="83"/>
                <count group_id="O2" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="111.41" spread="14.25"/>
                    <measurement group_id="O2" value="112.97" spread="12.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Hemoglobin on Day 2 Compared to Preoperatively</title>
        <time_frame>preoperatively and two days after surgery</time_frame>
        <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis for various reasons.</population>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hemoglobin on Day 2 Compared to Preoperatively</title>
          <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis for various reasons.</population>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="98"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.265" spread="1.443"/>
                    <measurement group_id="O2" value="-2.359" spread="1.246"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Hematocrit on Day 2 Compared to Preoperatively</title>
        <time_frame>preoperatively and two days after surgery</time_frame>
        <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis for various reasons</population>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hematocrit on Day 2 Compared to Preoperatively</title>
          <population>All patients enrolled in study were subject to analysis; occasionally a patient's levels were not taken or were not available for analysis for various reasons</population>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="98"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.013" spread="4.183"/>
                    <measurement group_id="O2" value="-7.418" spread="3.904"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Drain Output</title>
        <time_frame>24 hours postoperatively</time_frame>
        <population>Drain output at 24 hours was recorded for all patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Drain Output</title>
          <population>Drain output at 24 hours was recorded for all patients.</population>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="97"/>
                <count group_id="O2" value="99"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="711" spread="287"/>
                    <measurement group_id="O2" value="702" spread="314.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Autologous Amount of Transfusion</title>
        <time_frame>three days postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Autologous Amount of Transfusion</title>
          <units>units of blood</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="93"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".828" spread=".746"/>
                    <measurement group_id="O2" value=".854" spread=".754"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Homologous Amount of Transfusion</title>
        <time_frame>three days postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Homologous Amount of Transfusion</title>
          <units>units of blood</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".247" spread=".525"/>
                    <measurement group_id="O2" value=".337" spread=".738"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Pain Scale at 6 Weeks</title>
        <description>A VAS is a measurement instrument that tries to measure a characteristic or attitude that cannot easily be measured.
The pain VAS scale measures pain intensity on a scale of 0 to 10, with 0=no pain. A higher score indicates greater pain intensity.</description>
        <time_frame>6 weeks postoperatively</time_frame>
        <population>Patients whose pain level at 6-week followup appointment was taken were included in analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Hemostatic Matrix</title>
            <description>2 vials of Floseal applied once at the end of surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>No intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Pain Scale at 6 Weeks</title>
          <description>A VAS is a measurement instrument that tries to measure a characteristic or attitude that cannot easily be measured.
The pain VAS scale measures pain intensity on a scale of 0 to 10, with 0=no pain. A higher score indicates greater pain intensity.</description>
          <population>Patients whose pain level at 6-week followup appointment was taken were included in analysis.</population>
          <units>points on visual analog pain scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="90"/>
                <count group_id="O2" value="88"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.753" spread="2.09"/>
                    <measurement group_id="O2" value="2.91" spread="2.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Hemostatic Matrix</title>
          <description>2 vials of Floseal applied once at the end of surgery</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>No intervention.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="99"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="99"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Paralytic Ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="99"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="97"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="99"/>
              </event>
              <event>
                <sub_title>Suture Abscess with Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="97"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="99"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Manipulation Under Anesthesia Needed to Achieve Improved Range of Motion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="97"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="99"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep Venous Thromboses</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="97"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="99"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Mark P. Figgie MD</name_or_title>
      <organization>Hospital for Special Surgery</organization>
      <phone>212-606-1932</phone>
      <email>figgiem@hss.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

